Carregant...
PROTACs are effective in addressing the platelet toxicity associated with BCL-X(L) inhibitors
BCL-X(L) is an anti-apoptotic protein that plays an important role in tumorigenesis, metastasis, and intrinsic or therapy-induced cancer drug resistance. More recently, BCL-X(L) has also been identified as a key survival factor in senescent cells. Accumulation of senescent cells has been indicated a...
Guardat en:
| Publicat a: | Explor Target Antitumor Ther |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Open Exploration
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8293695/ https://ncbi.nlm.nih.gov/pubmed/34296214 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.37349/etat.2020.00017 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|